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B cell follicles are specialized microenvironments that support events necessary for humoral immunity [1] [2] [3] . After antigen encounter, activated B cells initially seek T-cell help at the follicle-T-zone boundary and then move to interfollicular and T-zone distal (outer) regions of the follicle [4] [5] [6] [7] [8] [9] [10] . Subsequently, some cells move to the follicle centre, become germinal centre B cells and undergo antibody affinity maturation 1, 2, 11 . Although germinal centres within follicles were described in 1885 (ref. 12) , the molecular cues mediating segregation of B cells between the outer and centre follicle have remained undefined. Here we present a role for the orphan G-protein-coupled receptor, Epstein-Barr virus induced molecule-2 (EBI2, also known as GPR183) 13 , in this process. EBI2 is expressed in mature B cells and increases in expression early after activation, before being downregulated in germinal centre B cells. EBI2 deficiency in mice led to a reduction in the early antibody response to a T-dependent antigen. EBI2-deficient B cells failed to move to the outer follicle at day 2 of activation, and instead were found in the follicle centre, whereas EBI2 overexpression was sufficient to promote B cell localization to the outer follicle. In mixed bone marrow chimaeras, EBI2-deficient B cells phenocopied germinal centre B cells in preferentially localizing to the follicle centre. When downregulation of EBI2 in wild-type B cells was antagonized, participation in the germinal centre reaction was impaired. These studies identify an important role for EBI2 in promoting B cell localization in the outer follicle, and show that differential expression of this receptor helps position B cells appropriately for mounting T-dependent antibody responses.
The propensity of B cells to migrate to the outer versus centre follicle at different stages of the antibody response, together with the established roles of G-protein-coupled receptors (GPCRs) in controlling lymphocyte positioning events, led us to address whether new GPCRs differentially expressed between early activated and germinal centre B cells may be involved in this subcompartmentalization. These criteria focused our attention on EBI2, a Ga i -coupled orphan receptor 13, 14 abundantly expressed in Epstein-Barr virus (EBV)-infected and activated human B cells, and downregulated in germinal centre B cells 15, 16 . To explore the expression pattern of mouse Ebi2, we generated a reporter mouse line carrying the enhanced green fluorescent protein (EGFP) gene inserted in place of the Ebi2 open reading frame ( Supplementary Fig. 1 ). Analysis of Ebi2 GFP/1 mice showed that EBI2 is upregulated during B cell maturation in the bone marrow, and is expressed in mature recirculating B cells in bone marrow, spleen and lymph nodes (Fig. 1a) . The expression of the GFP reporter tracked closely with changes in Ebi2 transcript abundance (Fig. 1b) . GFP levels were further upregulated after B-cell receptor (BCR) engagement with anti-IgM, or combined anti-IgM and anti-CD40 stimulation (Fig. 1c) . To examine expression after receipt of T-cell help, we used an adoptive transfer system in which B cells from C57BL/6 (B6) Ebi2 GFP/1 mice were transferred to the coisogenic strain, bm12, that bears a three amino acid difference in the I-A b major histocompatibility complex (MHC) class II molecule and contains a high frequency of I-A b responsive helper T cells 6, 17 . This approach permits tracking of an activated B cell population in non-transgenic mice at early time points after receiving T-cell help. Two days after adoptive transfer of anti-IgM-stimulated B cells, we found higher GFP expression in B cells transferred to bm12 compared to B6 recipients, indicating that interaction with helper T cells promoted EBI2 upregulation (Fig. 1d) . EBI2 expression was maintained in plasma cells but was markedly (,25-fold) downregulated in germinal centre B cells (Fig. 1a, b) . Most CD4 T cells and a smaller fraction of CD8 T cells also expressed EBI2, although at lower levels than B cells (Fig. 1a, b) . In sections, GFP was detectable throughout the follicle and T zone, but was almost undetectable within germinal centres, identified by their expression of GL7 (also known as LY77), making these structures appear as EBI2-deficient islands in a 'sea' of EBI2-expressing cells (Fig. 1e ).
An initial analysis of lymphoid tissues from EBI2-deficient mice showed the presence of organized follicles and T-cell compartments, and the mice had normal numbers of B and T cells ( Supplementary  Fig. 2 and data not shown). Movement of activated B cells to the follicle-T-zone boundary within 6 h of BCR stimulation occurred similarly for EBI2-deficient and wild-type cells (Fig. 2a) , suggesting that BCR-mediated EBI2 induction ( Fig. 1) is not required for this CCR7-dependent relocalization event 8 . We then asked whether the next stage(s) of activated B cell migration that occurs during T-dependent responses, movement to the outer follicle and interfollicular regions, were EBI2-dependent. To permit in situ tracking of activated B cells responding to T-cell help, we used the bm12 adoptive transfer approach introduced earlier. Littermate control B cells that had received anti-IgM stimulation were able to respond to T-cell help within bm12 recipients and relocalized to the outer follicle at day 2 (Fig. 2b) , as did cotransferred wild-type Igh a B cells (Fig. 2b) , consistent with earlier studies using immunoglobulin-transgenic B cells 6 . In contrast, EBI2-deficient B cells were unable to localize to this region and instead favoured the central area of the follicle (Fig. 2b) . To determine whether upregulation of EBI2 could be sufficient to control B cell localization to the interfollicular and outer follicle regions within lymphoid tissues, we transduced B cells with Ebi2-encoding or control retroviruses and transferred them to wild-type recipients. One day later, the EBI2-overexpressing cells, identified by expression of a human CD4 reporter, were situated in interfollicular regions and in the outer follicle (Fig. 2c ). This contrasted with the distribution of B cells transduced with the control retrovirus, where the cells distributed uniformly within the follicle (Fig. 2c) . Thus EBI2 seems to be both necessary and sufficient to promote positioning of activated B cells in the outer follicle and interfollicular regions. Consistent with an essential role for EBI2 in the correct positioning of B cells during the early phases of T-dependent humoral responses, EBI2-deficient mice mounted a reduced day 7 IgG1 antibody response to nitrophenyl-chicken gamma-globulin (NP-CGG) in alum (Fig. 2d) . The IgM response was not affected (Fig. 2d) .
As another approach to examine the role of EBI2 in determining B cell localization, we examined cell distribution in 20:80 mixed bone marrow chimaeras that contained a minority of EBI2-deficient cells (20% Igh b EBI2-deficient or littermate control and 80% Igh a wildtype). Notably, EBI2-deficient B cells selectively localized in a germinal-centre-like location at the centre of follicles in spleen, lymph nodes and Peyer's patches of the bone marrow chimaeras (Fig. 3a) . These foci of cells were not germinal centres as they maintained high expression of IgD and lacked expression of GL7 (Fig. 3a and Supplementary Fig. 3 ). In contrast, EBI2-deficient and wild-type T cells appeared intermingled throughout the T zone (Supplementary Fig. 4) . Analysis of 90:10 mixed bone marrow chimaeras containing mostly EBI2-deficient (or littermate control) cells showed that EBI2-deficient B cells colocalized with the CD35 1 (also known as CR1
1 ) follicular dendritic cell (FDC) network at the centre of follicles, whereas the minor population of wild-type B cells in these mice was partially excluded from this area and enriched in interfollicular regions or outer follicles (Fig. 3b) . Similar findings were made in lymph nodes and Peyer's patches ( Supplementary  Fig. 5 ). It seems possible that in mice in which most B cells lack EBI2, there is increased EBI2 ligand availability and wild-type B cells predominate at the sites of ligand production. In control mixed bone marrow chimaeras reconstituted with a minority (20:80) or majority (90:10) of Ebi2 1/1 bone marrow, the two types of wild-type B cells were intermingled in both the follicle centre and periphery (Fig. 3a, b and Supplementary Figs 3 and 5) . FDCs are dependent on lymphotoxin (LT) LTa1b2 for their maintenance 18 . To test whether the segregation of wild-type and EBI2-deficient B cells was dependent on FDCs, we treated mixed bone marrow chimaeras with LTbRimmunoglobulin, an LTa1b2 antagonist 19 , for 2-3 weeks. The CD35 1 FDC networks were depleted after treatment (Fig. 3c ) as expected 19, 20 . Under these conditions, wild-type and EBI2-deficient cells no longer showed a segregated distribution in splenic B cell areas (Fig. 3c) , suggesting a role for FDCs or other LTa1b2-dependent cells in this process. In mice that lack CXCL13-a chemokine made broadly by the follicular stromal cell network 20, 21 -B cell localization in the outer splenic white-pulp (where follicles would normally be located) is reduced but not completely blocked 22 (Fig. 3d) . In CXCL13-deficient mice reconstituted with a mixture of EBI2-deficient and wild-type bone marrow, EBI2-deficient B cells were selectively diminished within the white-pulp cords and instead accumulated in the marginal zone that surrounds the white pulp (Fig. 3d) . These findings provide further evidence for EBI2-mediated attraction of B cells to the outer white-pulp.
These findings suggested that EBI2 downregulation in germinal centre B cells may promote their positioning at the follicle centre. To test directly the significance of EBI2 downregulation during germinal centre development, we enforced constitutive EBI2 expression in hen egg lysozyme-specific immunoglobulin-transgenic B cells using retroviral gene transduction, and then tested their ability to participate in germinal centre and plasma cell responses after short-term adoptive transfer to hen egg lysozyme-immunized hosts (Fig. 4a) . The frequency of Ebi2 or control-vector transduced B cells among the germinal centre and plasma cell populations was tracked using the CD4 reporter. By flow cytometric analysis, Ebi2-transduced cells showed a reduced ability to participate in germinal centre responses compared to vector-transduced cells, while participating with wildtype efficiency in the plasma cell response (Fig. 4a, b) . Although some Ebi2-transduced cells could take on a germinal centre phenotype (Fig. 4a) , the cells were unable to position in germinal centres ( Fig. 4c and Supplementary Fig. 6 ). Cells transduced with the control vector were readily detected within germinal centres ( Fig. 4c and Supplementary Fig. 6 ). Ebi2-transduced cells contained Ebi2 transcripts in amounts within twofold of those present in follicular B cells, and at least 25-fold higher than in germinal centre B cells (Supplementary Fig. 6 ). These experiments suggest that EBI2 downregulation is necessary for localization of developing germinal centre B cells to the follicle centre.
In summary, we establish that EBI2 is upregulated in B cells after BCR and CD40 engagement and is necessary to promote the positioning of activated B cells to interfollicular regions and the outer follicle. Cognate B cells interact with helper T cells and undergo proliferation in these regions 7, 10 . Defects in these processes are probably responsible for the diminished ability of EBI2-deficient mice to mount an early T-dependent IgG antibody response. Our findings suggest EBI2 is needed within B cells for these events, but we do not exclude that it also has a role in directing activated CD4 helper T cells and possibly other cell types to these regions. Germinal centre B cells markedly downregulate EBI2, a change that seems to be necessary to favour localization of activated B cells at the follicle centre, in association with the antigen-presenting and germinal-centre-supportive 23 FDC network. BCL6, a transcription factor required for germinal centre development, negatively regulates EBI2 expression 15 . We suggest that by favouring appropriate niche occupancy, negative regulation of EBI2 represents an important component of the Bcl6 gene expression program directing germinal centre over plasma cell fate. Although the ligand for EBI2 remains undefined, we speculate that it is more concentrated in the outer compared to centre follicle as well as in interfollicular regions. We propose that although CXCR5 is sufficient to promote B cell localization in follicles 22, 24 , cells expressing EBI2 are more strongly attracted to the outer follicle compared to cells lacking this receptor. A further FDC-derived cue may favour positioning in the centre follicle, and when cells lose responsiveness to EBI2 ligands, positioning in response to this cue is dominant. The activity of EBI2 provides a possible explanation for why CXCR5-deficient B cells continue to localize in interfollicular areas and in regions corresponding to the outer follicle 22, 24 . Our findings may also help explain the niche preferences of certain B cell lymphomas, particularly follicular centre lymphoma 25 . Indeed, expression array studies demonstrate that EBI2 is downregulated in follicular and germinal centre lymphomas 16, 26 . Moreover, it seems possible that the marked EBI2 induction observed early after EBV infection 13 serves as a mechanism used by the virus to promote positioning in niches that favour the survival of the infected B cells.
METHODS SUMMARY
EGFP was inserted in place of the Ebi2 open reading frame within E14 (129) embryonic stem cells using standard procedures, and Ebi2 GFP/1 mice were backcrossed to C57BL/6 for six generations. Six-to-twelve-week-old C57BL/6 mice were from either the National Cancer Institute or Jackson Laboratories. 27 and CXCL13-deficient mice 22 were from an internal colony. Bone marrow chimaeras were generated as described 11 and analysed after 6-12 weeks. NP-CGG immunizations were performed using 50 mg NP-CGG (Solid Phase Sciences) in Alum (Accurate Chemical & Scientific Corp.). The retroviral construct was made by inserting the mouse Ebi2 open reading frame, with a preprolactin-Flag leader sequence 28 in place of the ATG, Endogenous naive B cells are stained brown (IgD) and germinal centres are detected in serial sections using GL7 (blue, lower panels). Scale bar, 100 mm.
into the MSCV2.2 retroviral vector containing cytoplasmic-domain-truncated human CD4 as an expression marker downstream of the internal ribosomal entry site 8 . B cells were isolated and in some cases labelled with 2.5 mM 5(and 6)-carboxy-fluorescein diacetate succinimidyl ester (CFSE, Molecular Probes) as described 29 . For in vivo analysis of EBI2 expression, 5-10 3 10 6 purified B cells as described previously 11 were transferred into bm12 recipients. Transduced cells were adoptively transferred 1 day after spin-infection for transfers to nonimmunized hosts or immediately after spin-infection for transfers to immunized hosts. For germinal centre experiments, B6 mice received 10 5 MD4 B cells and 10 5 OTII CD4 1 T cells at day 1, were intraperitoneally immunized with 50 mg HEL-OVA in RIBI adjuvant system (Sigma) at day 0, and received approximately 10 6 Ebi2 or control-vector-transduced cells at day 1. Mice were analysed on day 5. Flow cytometry, ELISA, immunohistochemsitry and immunofluorescence microscopy were performed using standard techniques and are detailed in the Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
